Melanie Gilgan accepts new patients on Medical News Today.
Melanie Gilgan
Be the first to review this provider!
Gulfport, MS
Accepting new patients
Clinical Overview
Melanie Gilgan works in Gulfport, MS as
Office Locations
-
Advanced Hearing Systems Inc.401 Security Sq, Gulfport, MS 39507
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Melanie Gilgan?
Step 1 of 3
Your review of Melanie Gilgan
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Hearing Instruments
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Melanie Gilgan's office is located at 401 Security Sq Gulfport, MS 39507. Get a map and directions to Melanie Gilgan's office here.
Melanie Gilgan does not have any reviews yet.
Claim Your Profile
Are you Melanie Gilgan?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
With the Targeting Aging with Metformin (TAME) trial looking to secure funding, Medical News Today speaks to 2 experts to discuss how a decades-old diabetes drug may help scientists slow biological aging and delay diseases.
A new statement from the Endocrine Society suggests that obesity treatment success should focus on improvements in heart, metabolic, liver, sleep, mental, and physical health, not just weight loss.
A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting that it may help reverse predicted biological aging.
